Cargando…

A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?

Since 2015, the World Health Organization (WHO) has recommended prioritising testing and treatment of tuberculosis (TB) infection (TBI) in 11 high-risk groups. With new options emerging for TB preventive treatment, we conducted a scoping review, in consultation with the WHO's Global Tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bigio, Jacob, Viscardi, Angelo, Gore, Genevieve, Matteelli, Alberto, Sulis, Giorgia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879343/ https://www.ncbi.nlm.nih.gov/pubmed/36631131 http://dx.doi.org/10.1183/16000617.0127-2022

Ejemplares similares

Isoniazid-resistant tuberculosis: A problem we can no longer ignore
por: Sulis, Giorgia, et al.
Publicado: (2020)

Tuberculosis: Epidemiology and Control
por: Sulis, Giorgia, et al.
Publicado: (2014)

Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis
por: Svadzian, Anita, et al.
Publicado: (2020)

Recent developments in the diagnosis and management of tuberculosis
por: Sulis, Giorgia, et al.
Publicado: (2016)

Improving the quality of tuberculosis care in the post-pandemic world
por: Bigio, Jacob, et al.
Publicado: (2021)

Implementation of tuberculosis prevention for exposed children, Burkina Faso
por: Sulis, Giorgia, et al.
Publicado: (2018)

Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination
por: Raviglione, Mario, et al.
Publicado: (2016)

Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Can we make an anti-world
Publicado: (2009)

Can we make an anti-world?
Publicado: (2009)

Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients
por: Kouanda, Seni, et al.
Publicado: (2020)

Bisphosphonate drug holidays: Can we recommend currently?
por: Tandon, Vishal R., et al.
Publicado: (2014)

Can we recommend varicocele surgery for men with hypogonadism?
por: Marquardt, Nilson, et al.
Publicado: (2023)

Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis
por: Sulis, Giorgia, et al.
Publicado: (2020)

Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review
por: Sulis, Giorgia, et al.
Publicado: (2023)

Antibodies Expand the Scope of Angiotensin Receptor Pharmacology
por: Skiba, Meredith A., et al.
Publicado: (2023)

Expanding the scope of medical mission volunteer groups to include a research component
por: Rovers, John, et al.
Publicado: (2014)

Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry
por: Longo, Christopher J.
Publicado: (2022)

Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week
por: Ouedraogo, Henri Gautier, et al.
Publicado: (2020)

How can we build and maintain the resilience of our health care professionals during COVID-19? Recommendations based on a scoping review
por: Rieckert, Anja, et al.
Publicado: (2021)

Antimatter mysteries Can we make an anti-world?
Publicado: (2009)

Resistance in tuberculosis: what do we know and where can we go?
por: Green, Keith D., et al.
Publicado: (2013)

The expanding scope of amyloid signalling
por: Daskalov, Asen, et al.
Publicado: (2021)

Expanding scope of TEMRA in autoimmunity
por: Perl, Andras, et al.
Publicado: (2023)

Expanding the scope of Endocrine Connections
por: Clark, A J
Publicado: (2023)

Diagnosis of latent tuberculosis: Can we do better?
por: Al-Orainey, Ibrahim O.
Publicado: (2009)

Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations
por: Hajizadeh, Anisa, et al.
Publicado: (2021)

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study
por: Matteelli, Alberto, et al.
Publicado: (2016)

Comparison of Different Types of Palatal Expanders: Scoping Review
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023)

Tuberculosis can cause anything in the world except pregnancy!
por: Pai, Vasudev B, et al.
Publicado: (2015)

How Can We Control the Prevalence of Tuberculosis among Cattle?
por: Trumbower, M. R.
Publicado: (1894)

Superbends expand the scope of Berkeley's ALS
Publicado: (2002)

Superbends expand the scope of Berkeley's ALS
por: Robin, D S, et al.
Publicado: (2002)

Expanding the scope and scale of microbiome research
por: Knight, Rob, et al.
Publicado: (2019)

Expanding Our Scope and Our Identity
por: Erdogan, Zeynep Madak, et al.
Publicado: (2022)

Asia emerges as a hotbed of diagnostic innovations for tuberculosis
por: Bigio, Jacob, et al.
Publicado: (2021)

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)

Extensively drug-resistant tuberculosis: epidemiology and management
por: Matteelli, Alberto, et al.
Publicado: (2014)

Most common reasons for primary care visits in low- and middle-income countries: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_baff7e2cseks03d9q1qpkc3hb9